Ursula Mirastschijski Selected Research

Ursula Mirastschijski Research Topics

Disease

13	Wounds and Injuries (Trauma) 12/2020 - 01/2002
5	Cicatrix (Scar) 11/2020 - 04/2014
3	Burns 12/2020 - 03/2013
3	Inflammation (Inflammations) 01/2020 - 10/2013
2	Infections 01/2018 - 01/2016
2	Leg Ulcer 01/2007 - 03/2002
2	Skin Ulcer 01/2007 - 03/2002
1	Rupture 05/2021
1	Pneumonia (Pneumonitis) 01/2020
1	COVID-19 01/2020
1	Blister (Bulla) 01/2020
1	Neoplasms (Cancer) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 08/2018
1	Hernia (Hernias) 01/2018
1	Pilonidal Sinus (Pilonidal Cyst) 06/2013
1	Abscess 06/2013
1	Carcinoma (Carcinomatosis) 06/2009
1	Superinfection 01/2007
1	Periodontitis 01/2004
1	Pathologic Constriction (Stenosis) 09/2003
1	Anastomotic Leak 09/2003

Drug/Important Bio-Agent (IBA)

8	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2002
4	Matrix Metalloproteinase InhibitorsIBA 01/2018 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
3	ZincIBA 01/2019 - 01/2007
3	CollagenIBA 01/2018 - 09/2003
2	Cadherins (E-Cadherin)IBA 05/2021 - 11/2020
2	Surface-Active Agents (Surfactants)IBA 01/2020 - 01/2020
2	EnzymesIBA 01/2019 - 01/2007
2	Virulence Factors (Pathogenicity Factors)IBA 01/2018 - 01/2016
2	GelatinasesIBA 01/2018 - 03/2002
2	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 01/2018 - 10/2004
2	Melanins (Melanin)IBA 01/2018 - 01/2016
1	Myosins (Myosin)IBA 05/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	calfactant (Infasurf)FDA Link 01/2020
1	Botulinum Toxins (Botulinum Toxin)IBA 08/2018
1	PlasticsIBA 06/2018
1	A-factor (Streptomyces)IBA 01/2018
1	Polypropylenes (Polypropylene)IBA 01/2018
1	CytokinesIBA 01/2018
1	Polyketide SynthasesIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2016
1	Silk FDA Link 04/2014
1	stratticeIBA 10/2013
1	SeleniumIBA 06/2013
1	CopperIBA 06/2013
1	Trace Elements (Biometals)IBA 06/2013
1	C-Reactive ProteinIBA 06/2013
1	batimastat (BB 94)IBA 03/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2010
1	Zinc Oxide FDA Link 01/2007
1	IonsIBA 01/2007
1	Transcription Factors (Transcription Factor)IBA 01/2007
1	Ointments (Pastes)IBA 01/2007
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 10/2004
1	Tryptophan (L-Tryptophan)FDA Link 10/2004
1	Hydroxyproline (4 Hydroxyproline)IBA 10/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2004
1	propylene glycol alginate ester (propylene glycol alginate)IBA 01/2004
1	AmelogeninIBA 01/2004
1	Peptide Hydrolases (Proteases)FDA Link 01/2004
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 09/2003
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2002
1	Messenger RNA (mRNA)IBA 03/2002
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2002
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2002
1	Serine Proteases (Serine Protease)IBA 01/2002
1	Aprotinin (Trasylol)FDA Link 01/2002
1	BB 3103IBA 01/2002

Therapy/Procedure

2	Critical Care (Surgical Intensive Care) 12/2020 - 03/2013
2	Therapeutics 03/2013 - 01/2007
1	Injections 08/2018
1	Sutures (Suture) 06/2018
1	Artificial Skin 01/2016
1	Minor Surgical Procedures (Minor Surgery) 06/2013
1	Musculoskeletal Manipulations (Manipulative Therapy) 03/2013
1	Pelvic Exenteration 06/2009
1	Topical Administration 01/2007